ALL and lymphoblastic lymphoma patients: short-term outcome by arm
| . | E coli–asparaginase N = 354 (100%) . | Erwinia-asparaginase N = 346 (100%) . | Odds ratio (95% CI) (P)5-150 . |
|---|---|---|---|
| CR not reached | 19 (5.4) | 31 (9.0) | 1.74 (0.93, 3.32) |
| after induction | (.078) | ||
| Remission failure | 7 (2.0) | 17 (4.9) | 2.56 (0.99, 7.39) |
| (.038) |
| . | E coli–asparaginase N = 354 (100%) . | Erwinia-asparaginase N = 346 (100%) . | Odds ratio (95% CI) (P)5-150 . |
|---|---|---|---|
| CR not reached | 19 (5.4) | 31 (9.0) | 1.74 (0.93, 3.32) |
| after induction | (.078) | ||
| Remission failure | 7 (2.0) | 17 (4.9) | 2.56 (0.99, 7.39) |
| (.038) |
Remission failure means patient never achieved CR at the end of induction-consolidation.
Fisher exact test.